Elanco Animal Health Inc·4

May 19, 4:37 PM ET

VanHimbergen Robert M 4

Research Summary

AI-generated summary

Updated

Elanco CFO Robert VanHimbergen Receives Stock Award

What Happened

  • Robert M. VanHimbergen, Elanco EVP and Chief Financial Officer, was granted 9.92 deferred stock units on May 15, 2026. The units were reported at $19.86 per share for a total reported value of about $197. This transaction is an award/grant (derivative deferred stock units), not an open-market purchase or sale.

Key Details

  • Transaction date and price: 2026-05-15 — 9.92 units @ $19.86 (total ≈ $197).
  • Filing date: Form 4 filed 2026-05-19 (timely within required filing window).
  • Shares owned after transaction: not specified in the provided filing details.
  • Transaction code/type: A (award/grant) — derivative instrument (deferred stock units).
  • Footnotes: F1 — each deferred stock unit equals the right to one share or cash equivalent. F2 — units settle in cash or shares after termination of employment or in a specified future year under the Executive Deferral and Stock Match Plan.

Context

  • Deferred stock units are a form of compensation that convert to shares or cash at a later date; they do not represent immediate open-market buying or selling. This small-value award (~$197) appears to be a routine compensation grant and should not be interpreted on its own as a signal of insider sentiment.